Therefore, our experiments suggest that GSK-3β could influence MM cell survival through MCL-1 and AKT-independent mechanisms, while GSK-3α could modulate BZ-induced MM cell apoptosis interfering with pathways controlling AKT and MCL-1 protein levels. Here, GSK3B is linked to Miyoshi myopathy.